Psychedelic Research Bulletin: September 2021

PTSF81 – Somatics, Reframing Trauma, and the 7 Lens Approach, with...

MindMed Joins Clinical Trials Transformation Initiative

The Therapeutic Effects of Psychedelics: 2A or Not 2A?-Part 2

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex...

Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the...

Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of...

MYND Diagnostics Inc. Announces Participation in a Monash University (Australia) Proposal...

Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities

PT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and...

Load more